Form D · Other Health Care

RENOVARO INC.

Los Angeles, CA · CIK 0001527728

Offering snapshot reported Feb 23, 2024 · SEC filing

Reported sold
$107M
Offering amount: $107M
Investors reported
8
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Feb 13, 2024
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Feb 23, 2024Initial$106,849,547No comparison8SEC filing
Sep 15, 2016InitialYet to sellNo comparison0SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
Yes
Sales commissions
$0
Finders' fees
$0
Form D file number
021-505979

Source: Form D, filed Feb 23, 2024. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Gregg Alton Director
Francois Binette Executive
Leni Boeren Director
Karen Brink Director
Carol Brosgart Director
Mark Dybul Director, Executive
Ruud Hendriks Director
Eric Leire Director, Executive
Jayne Mc Nicol Director
Avram Miller Director
N. E. Nielsen Director
Aldo Michael Noes Petersen Director
Luisa Puche Executive
James Sapirstein Director
Rene Sindlev Director

Issuer details

Industry: Other Health Care (See others in industry)

Address:
2080 Century Park East Suite 906
Los Angeles, CA, 90067